Newly discovered elovanoids called a 'transformative new concept of biology'

July 13, 2017
Nicolas G. Bazan, M.D., Ph.D. is pictured. Credit: Darryl Schmitt for LSU Health New Orleans Neuroscience Center of Excellence

Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered a new class of mediators, or biochemical triggers that he named elovanoids (ELVs). Elovanoids are the first bioactive chemical messengers made from omega-3 very long chain polyunsaturated fatty acid (VLC-PUFAs,n-3) that are released in response to cell injury or when cells are confronted with adversities for survival. This discovery provides the first evidence of the existence of elovanoids and of their significant role in protecting and sustaining retinal pigment epithelial (RPE) and photoreceptor cell survival. The work is published online in Nature Research's Scientific Reports.

"We believe this discovery represents a new concept of biology that will be transformative in medicine," says Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans.

This research uncovers a mechanistic breakthrough in the understanding of how are protected from impending damage. Uncompensated oxidative stress is often an early event associated with retinal, neuronal or heart cell death, and the retinal pigment epithelium and retina are under continuous stress.

"We found that elovanoids have unique structures and that they enhance the expression of pro-survival proteins in cells undergoing uncompensated oxidative stress," says Dr. Bazan.

Bazan's lab discovered, identified and structurally characterized this new class of molecules in human retinal pigment epithelial cells. Due to their biology, they are classified as mediators and are derived from docosahexaenoic acid (DHA). DHA is present abundantly in the retina and also serves as a precursor of signaling molecules called docosanoids that promote cell stability and equilibrium and act to protect the cell. The DHA- or eicosapentaenoic acid (EPA)-derived 26 carbon fatty acid is a molecule acted upon by the elongating enzyme ELOVL4, which is expressed in photoreceptor cells. ELOVL4 mutations are linked to vision loss and neuronal dysfunction. This has implications for developing new therapies for conditions such as Stargardt's disease and other forms of .

Bazan and his team found that ELVs are made from 32 or 34 carbon-length fatty acid precursors produced naturally in human epithelial (RPE) cells. Most of the known lipid mediators or messengers are derived from 18, 20, or 22 carbon-length fatty acid precursors, including prostaglandins, leukotrienes, lipoxyns, endocanabinoids, resolvins and docosanoids. Elovanoids have structures reminiscent of docosanoids but with different physicochemical properties and alternatively regulated biosynthetic pathways. That elovanoids are longer than all known mediators may be the key to their potency. The longer elovanoids may be able to reach and bind for a longer period of time to receptors in cells necessary to induce cell survival.

"This is a very exciting discovery that opens a path forward to expand the science of neuroprotection," says Bazan. "Our research reveals potential therapeutic targets for retinal degeneration diseases. In addition, these findings provide major conceptual advances of broad relevance for the survival of neural as well as any other cells in the body by turning on neuroprotection using a set of molecules that mimic how the body naturally activates this protection."

Explore further: Research shows fish oil component helps damaged brain and retina cells survive

More information: Bokkyoo Jun et al, Elovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrity, Scientific Reports (2017). DOI: 10.1038/s41598-017-05433-7

Related Stories

Research shows fish oil component helps damaged brain and retina cells survive

April 21, 2017
A team of researchers led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans School of Medicine, has shown for the first time that NDP1, a signaling molecule ...

Team discovers retina protein that may help conquer blindness

March 4, 2015
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the LSU Health New Orleans Neuroscience Center of Excellence, discovered a protein in the retina that is crucial for vision. The paper reports, for the ...

Team discovers key to preventing blindness and stroke devastation

January 30, 2015
Research led by Nicolas Bazan, MD, PhD, Boyd Professor, Ernest C. and Yvette C. Villere Chair of Retinal Degeneration Research, and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered ...

Research finds protein that prevents light-induced retinal degeneration

February 12, 2013
Research led by Minghao Jin, PhD, Assistant Professor of Ophthalmology and Neuroscience at the LSU Health Sciences Center New Orleans Neuroscience Center of Excellence, has found a protein that protects retinal photoreceptor ...

Recommended for you

Researchers find infectious prions in Creutzfeldt-Jakob disease patient skin

November 22, 2017
Creutzfeldt-Jakob disease (CJD)—the human equivalent of mad cow disease—is caused by rogue, misfolded protein aggregates termed prions, which are infectious and cause fatal damages in the patient's brain. CJD patients ...

Surprising roles for muscle in tissue regeneration, study finds

November 22, 2017
A team of researchers at Whitehead has illuminated an important role for different subtypes of muscle cells in orchestrating the process of tissue regeneration. In a paper published in the November 22 issue of Nature, they ...

Study reveals new mechanisms of cell death in neurodegenerative disorders

November 22, 2017
Researchers at King's College London have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.